Synthesis of RP 48497, an impurity of eszopiclone
- Molecules. 2008 Aug 22;13(8):1817-21. doi: 10.3390/molecules13081817.
- 1. Key Lab of New Drug Design and Discovery of Liaoning Province, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. [email protected].
RP 48497 is a photodegradation product of eszopiclone, a non-benzodiazepine sedative-hypnotic used in the treatment of insomnia. We report herein the first synthesis of RP 48497 via reduction, chlorination, and recyclization of 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydropyrrolo[3,4-b]pyrazin-5-one (3), a key intermediate in the synthesis of eszopiclone. The structure of RP 48497 was confirmed by its (1)H-NMR and MS data. The mechanism of the reduction step in the synthesis of RP 48497 was also studied and the key parameters were determined. These findings should be important for quality control purposes in the manufacture of eszopiclone.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Drug MetaboliteResearch Areas: Neurological Disease
-
Research Areas: Neurological Disease
-
Research Areas: Neurological Disease
-
Research Areas: Neurological Disease
-
target: Drug MetaboliteResearch Areas: Neurological Disease